olivLaw · US equity research
Alexandria Real Estate Equities, Inc. ARE
Real Estate Investment Trusts · SIC 6798 · Vertical: Real Estate Investment Trusts (SIC 6798)
Alexandria Real Estate Equities is a REIT specialised in life science real estate, developing and operating Megacampus ecosystems in top innovation clusters in the United States. The company is going through a period of pressure: weaker occupancy, moderate demand for laboratory space and a dividend cut, but it keeps a solid balance sheet and a long debt maturity profile. The figure of 20.75 billion USD is total market capitalisation at year-end 2025, and total revenues of 3.03 billion USD in 2025 show the scale of the business.
At the close of 04 Nov 2026, Alexandria Real Estate Equities, Inc. (ARE) stock was 46.00 USD (+8.80% on the day), with market capitalisation 8.0 bn USD, dividend yield 6.26%, beta 0.78, 52-week range 39.91–59.69 USD. Latest reported quarter (Q3 2026): revenue of 671.2 m USD (−10.7% YoY), net income of -637.7 m USD, diluted EPS -3.74 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 56.3
- strong (55–70)
- Bollinger (20, 2)
- 39.13 – 46.09
- in the upper half of the band · %B 0.99 · band width 16.3%
- SMA 50 / 200
- 47.51 / 49.34
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -1.29 / -1.84
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +0.3% | −1.1% | +1.4 pp | — |
| 3 months | −8.2% | −0.5% | −7.7 pp | — |
| 6 months | +0.4% | +4.4% | −4.0 pp | — |
| Year to date | −6.0% | +12.3% | −18.3 pp | — |
| 1 year | −14.8% | +13.5% | −28.3 pp | +7.5% |
| 3 years | −55.0% | +76.4% | −131.5 pp | +19.0% |
| 5 years | −77.7% | +63.7% | −141.4 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 788.9 m | 758.2 m | 762.0 m | 751.9 m | 754.4 m | 671.0 m | 662.8 m | 671.2 m |
| Depreciation & amortisation | 330.1 m | 342.1 m | 346.1 m | 340.2 m | 322.1 m | 305.4 m | 304.4 m | 304.4 m |
| Interest expense | 55.7 m | 50.9 m | 55.3 m | 54.9 m | 65.7 m | 64.6 m | 64.3 m | 79.7 m |
| Net income | -62.2 m | -8.9 m | -107.0 m | -232.8 m | -1.1 bn | 361.7 m | -72.8 m | -637.7 m |
| Diluted EPS | -0.36 ≈ | -0.07 | -0.64 | -1.38 | -6.34 ≈ | 2.10 | -0.43 | -3.74 |
| Operating cash flow | 274.2 m | 207.9 m | 460.2 m ≈ | 433.5 m ≈ | 312.4 m | 196.6 m | 337.0 m ≈ | 341.8 m ≈ |
| Dividends paid | 227.2 m | 230.0 m | 227.2 m ≈ | 227.2 m ≈ | 227.0 m | 123.8 m | 123.8 m ≈ | 123.8 m ≈ |
| Share repurchases | 50.1 m | 208.2 m | 0 ≈ | 0 ≈ | 0 | 0 | 0 ≈ | 0 ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3 bn | 1.5 bn | 1.9 bn | 2.1 bn | 2.6 bn | 2.9 bn | 3.1 bn | 3.0 bn |
| Revenue YoY | +17.7% | +15.4% | +23.1% | +12.1% | +22.5% | +11.5% | +8.0% | −2.9% |
| Net income | 379.3 m | 363.2 m | 771.0 m | 571.2 m | 521.7 m | 103.6 m | 322.9 m | -1.4 bn |
| Net income YoY | +124.3% | −4.3% | +112.3% | −25.9% | −8.7% | −80.1% | +211.6% | −542.7% |
| Diluted EPS | 3.52 | 3.12 | 6.01 | 3.82 | 3.18 | 0.54 | 1.80 | -8.44 |
| Diluted EPS YoY | +122.8% | −11.4% | +92.6% | −36.4% | −16.8% | −83.0% | +233.3% | −568.9% |
| net % | 28.6% | 23.7% | 40.9% | 27.0% | 20.1% | 3.6% | 10.4% | -47.2% |
| Free cash flow | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 549.1 m USD
- Financial debt
- 12.4 bn USD
- Net debt
- 11.9 bn USD
- Equity
- 19.1 bn USD
- Total assets
- 34.1 bn USD
- Debt / equity
- 0.65x
- Current ratio
- unavailable
- ROE
- -6.9%
- ROA
- -4.0%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 1.9 bn | 2.1 bn | 2.6 bn | 2.9 bn | 3.1 bn | 3.0 bn | SEC (XBRL)· 26 Jan 2026verified |
| Depreciation & amortisation | 698.1 m | 821.1 m | 1.0 bn | 1.1 bn | 1.2 bn | 1.4 bn | SEC (XBRL)· 26 Jan 2026verified |
| Interest expense | 171.6 m | 142.2 m | 94.2 m | 74.2 m | 185.8 m | 226.7 m | SEC (XBRL)· 26 Jan 2026verified |
| Net income | 771.0 m | 571.2 m | 521.7 m | 103.6 m | 322.9 m | -1.4 bn | SEC (XBRL)· 26 Jan 2026verified |
| Diluted EPS | 6.01 | 3.82 | 3.18 | 0.54 | 1.80 | -8.44 | SEC (XBRL)· 26 Jan 2026verified |
| Weighted average diluted shares | 126.5 m | 147.5 m | 161.7 m | 170.9 m | 172.1 m | 170.3 m | SEC (XBRL)· 26 Jan 2026verified |
| Dividend per share | 4.24 | 4.48 | 4.72 | 4.96 | 5.19 | 4.68 | SEC (XBRL)· 26 Jan 2026verified |
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 568.5 m | 361.3 m | 825.2 m | 618.2 m | 552.1 m | 549.1 m | SEC (XBRL)· 26 Jan 2026verified |
| Property, plant & equipment, net | 31.1 m | 26.4 m | 23.2 m | 26.6 m | 39.6 m | 70.3 m | SEC (XBRL)· 26 Jan 2026verified |
| Total assets | 22.8 bn | 30.2 bn | 35.5 bn | 36.8 bn | 37.5 bn | 34.1 bn | SEC (XBRL)· 26 Jan 2026verified |
| Long-term debt | 7.6 bn | 8.8 bn | 10.2 bn | 11.3 bn | 12.2 bn | 12.4 bn | SEC (XBRL)· 26 Jan 2026verified |
| Total liabilities | 9.4 bn | 11.2 bn | 12.8 bn | 14.1 bn | 15.1 bn | 14.9 bn | SEC (XBRL)· 26 Jan 2026verified |
| Equity | 13.4 bn | 19.0 bn | 22.7 bn | 22.6 bn | 22.4 bn | 19.1 bn | SEC (XBRL)· 26 Jan 2026verified |
| Shares outstanding at year end | 136.7 m | 159.9 m | 173.1 m | 175.0 m | 173.1 m | 173.3 m | SEC (XBRL)· 27 Oct 2025verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 882.5 m | 1.0 bn | 1.3 bn | 1.6 bn | 1.5 bn | 1.4 bn | SEC (XBRL)· 26 Jan 2026verified |
| Investing cash flow | -3.3 bn | -7.1 bn | -5.1 bn | -2.5 bn | -1.5 bn | 362.1 m | SEC (XBRL)· 26 Jan 2026verified |
| Financing cash flow | 2.8 bn | 5.9 bn | 4.2 bn | 674.2 m | -93.3 m | -1.8 bn | SEC (XBRL)· 26 Jan 2026verified |
| Dividends paid | 533.0 m | 656.0 m | 757.7 m | 847.5 m | 898.6 m | 911.5 m | SEC (XBRL)· 26 Jan 2026verified |
| Share repurchases | — | — | 0 | 0 | 50.1 m | 208.2 m | SEC (XBRL)· 26 Jan 2026verified |
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Market and valuation
9 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 4 of at least 6
- score weight coverage: 50.0% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 8.0 bn USD
Key indicators
Coverage and freshness
Score by group
50% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 61.50 – 241.99 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- Net asset value (NAV)unavailable · input data missing
- Dividend discount (DDM)61.50 – 82.71 (Mid 70.54)
- Peers: P/B92.33 – 241.99 (Mid 161.02)32 companies used · median multiple 1.9x · quartiles 1.1x – 2.8xAKR, ALX, BRX, CHCT, COLD, DLR, DOC, EPR, ESS, EXR, FPI, FRT, GNL, HST, IRT, JBGS, KIM, LXP, NHI, O, PLD, PSA, RLJ, SELF, SITC, SLG, STAG, UDR, VICI, VMRK, VTR, WELL
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 50.0% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROE · Quality | -9.1% | 6 (vs peers) | 13% |
| EBITDA margin · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 5.3% | 53 (on a fixed band) | 17% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| P/B · Valuation | 0.5x | 100 (vs peers) | 39% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| Dividend yield · Returns | 6.3% | 82 (vs peers) | 30% |
| Payout ratio (EPS) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partialunavailable · 0/2 factors with a value
- Growth53/100 · 1/1 factors with a value
- Quality· partial6/100 · 1/2 factors with a value
- Returns· partial82/100 · 1/2 factors with a value
- Valuation· partial100/100 · 1/2 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE). Latest full fiscal year: 2025; data up to 2026-09-30.
Figures computed from the financial statements: revenue 3.0 bn USD in 2025; YoY growth -2.9%; net margin -51.8%; ROE -9.1%.
The estimated value range is 76.91–162.35 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 115.78 USD, the price of 46.00 USD leaves a potential of 151.7% (value / price − 1) and a margin of safety of 60.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 50.0% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- P/B: 0.5x
- Dividend yield: 6.3%
- The price is below the estimated value range
What contradicts it
- ROE: -9.1%
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): EBITDA margin, Net debt / EBITDA, Interest coverage, P/E (TTM), Payout ratio (EPS).
Versus the vertical median
Real Estate Investment Trusts (SIC 6798) · same industry (4-digit SIC) · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| WELLWelltower Inc. | 181.9 bn | 106.2 | 4.0% | 12.7% | +35.6% | +19% / +178% |
| PLDPrologis, Inc. | 122.5 bn | 33.1 | 7.1% | 42.5% | +7.2% | +2% / +14% |
| EQIXEquinix Inc | 104.3 bn | 63.3 | 11.5% | 16.4% | +5.4% | +40% / +29% |
| AMTAmerican Tower Corporation | 90.4 bn | 27.3 | 90.6% | 30.7% | +5.1% | +7% / −7% |
| DLRDigital Realty Trust, Inc. | 65.0 bn | 48.3 | 6.2% | 21.7% | +10.0% | +15% / +33% |
| PSAPublic Storage | 64.0 bn | 34.9 | 16.0% | 37.8% | +2.7% | +25% / +32% |
| ORealty Income Corporation | 56.3 bn | 40.8 | 3.6% | 22.9% | +9.1% | +3% / +10% |
| VTRVentas, Inc. | 47.2 bn | 167.8 | 1.9% | 4.0% | +18.5% | +11% / +95% |
| CCICrown Castle Inc. | 39.2 bn | 48.6 | — | 20.1% | −4.4% | +1% / −21% |
| IRMIron Mountain Inc | 35.3 bn | 84.0 | — | 5.7% | +12.2% | +37% / +85% |
| EXRExtra Space Storage Inc. | 33.6 bn | 32.7 | 7.9% | 29.9% | +3.7% | +21% / +24% |
| VICIVICI Properties Inc. | 27.8 bn | 11.6 | 8.3% | 56.5% | +4.1% | −12% / −16% |
| VMRKVivmark Residential | 23.9 bn | 27.9 | 8.1% | — | +4.8% | +3% / +12% |
| SBACSba Communications Corporation | 20.7 bn | 21.1 | — | 34.5% | +5.1% | +1% / −21% |
| HSTHost Hotels & Resorts, Inc. | 17.9 bn | 17.5 | 15.8% | 16.5% | +7.6% | +48% / +49% |
| ESSEssex Property Trust, Inc. | 17.5 bn | 41.7 | 8.0% | 22.7% | +6.4% | +3% / +27% |
| KIMKimco Realty Corporation | 17.4 bn | 28.6 | 5.8% | 27.8% | +5.1% | +25% / +34% |
| DOCHealthpeak Properties, Inc. | 13.9 bn | 37.1 | 4.9% | 12.3% | +4.5% | +10% / +16% |
| UDRUDR, Inc. | 11.8 bn | 17.5 | 21.8% | 40.8% | +2.4% | +2% / +11% |
| FRTFederal Realty Investment Trust | 9.9 bn | 19.9 | 15.6% | 38.6% | +6.4% | +16% / +20% |
| BRXBrixmor Property Group Inc. | 9.3 bn | 22.0 | 14.2% | 30.0% | +6.7% | +16% / +40% |
| AREAlexandria Real Estate Equities, Inc. | 8.0 bn | — | -9.1% | -51.8% | −2.9% | −15% / −55% |
| STAGSTAG Industrial, Inc. | 7.3 bn | 27.1 | 7.6% | 29.9% | +10.1% | −4% / +6% |
| EPREpr Properties | 4.7 bn | 16.8 | 12.7% | 38.8% | +2.9% | +16% / +36% |
| COLDAmericold Realty Trust, Inc. | 4.3 bn | — | -16.5% | -17.4% | −2.4% | +40% / −46% |
1- and 3-year price returns: for ARE from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Alexandria Real Estate Equities is a REIT specialised in life science real estate, developing and operating Megacampus ecosystems in top innovation clusters in the United States. The company is going through a period of pressure: weaker occupancy, moderate demand for laboratory space and a dividend cut, but it keeps a solid balance sheet and a long debt maturity profile. The figure of 20.75 billion USD is total market capitalisation at year-end 2025 1, and total revenues of 3.03 billion USD in 2025 1 show the scale of the business.
SWOT
Strengths
- High-quality tenants, including investment-grade and large cap companies, support stable revenue and long-term contracts 1. Almost all leases include annual rent escalations 2.
- Experience across more than three decades and a network of industry relationships help the company identify and attract new tenants 1.
Weaknesses
- Occupancy of operating properties fell to 87.1% in the third quarter of 2026, below historical levels 2. Total revenues declined in 2025 1.
- The company recorded significant net losses in 2025 and 2026, including large impairments on assets held for sale 12.
- Dependence on the life science sector makes the company exposed to changes in research funding and drug pricing policy 1.
Opportunities
- Sales of non-core assets and partial interests can fund investments without overly increasing debt 2. Higher rents on renewals could improve revenue if demand recovers 1.
- Redeveloping existing space into laboratories could deliver better returns if demand for Class A/A+ space returns 1.
- Lower general and administrative costs could widen operating margins if the savings are sustained 1.
Threats
- The large supply of laboratory space in top markets could keep pressure on rents and occupancy 1.
- Changes in public policy, such as research funding and tariffs, could reduce demand from tenants in the industry 1.
- If the market for asset sales remains weak, the company could obtain lower prices on divestments 1.
Risks
- Falling occupancy and oversupplyhigh
Property occupancy has declined and the supply of laboratory space exceeds demand in key markets 12. If absorption stays slow, revenues could remain under pressure.
- Asset impairments and net losseshigh
Net losses and significant impairments on assets held for sale show that the value of some properties has fallen 12. This could weigh on shareholders' equity.
- Public policy and research fundingmedium
Policy changes and funding cuts from public agencies can affect tenants and the companies in which the company invests 1.
- Refinancing and capital needsmedium
The company relies on asset sales and debt issuance to fund its capital plan; if markets become more expensive, financing costs could rise 12.
- Venture capital investmentslow
Investments in life science companies expose the company to venture-type risks and may limit its ability to diversify 1.
Investment thesis
What would need to be true (bull case)
- The company has a resilient balance sheet, with substantial liquidity and one of the longest debt maturity profiles in the REIT sector 2. If demand for Class A/A+ Megacampus space recovers, occupancy and revenues could gradually return 12.
- The Megacampus platform generates most of the revenue and attracts high-quality tenants on long leases 3. If leasing continues at the strong third-quarter 2026 pace, revenues could benefit 2.
- Lower general and administrative costs and asset sales could support margins and fund investments without excessive borrowing 12.
What would break the thesis
- Property occupancy has declined and the supply of laboratory space remains large in key markets 12. If demand does not return, revenues could keep falling.
- Recent net losses and impairments show that some assets are worth less than previously estimated 12. This could pressure equity and dividends.
- Dependence on research funding and drug pricing could cause tenants to defer leasing decisions, prolonging uncertainty 1.
What to watch
- Trend in occupancy of operating properties and temporarily vacant spaceQ4 2026
- Achievement of the net debt to Adjusted EBITDA target of 5.6x to 6.2xQ4 2026
- Pace of asset sales and partial interest sales against the capital target2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Alexandria was founded in 1994 as a Maryland corporation that elected REIT tax status and presents itself as the pioneer of the life science real estate niche 1. The company owns, develops and manages Class A/A+ properties grouped in Megacampus ecosystems in clusters such as Greater Boston, the San Francisco Bay Area and San Diego 1. Its tenants include pharmaceutical and biotechnology companies, medical device makers, research institutions and government agencies 1. The company also runs a venture capital platform that invests in transformative life science companies 1.
Segments
Megacampus and Class A/A+ properties
The Megacampus platform accounts for most rental revenue, at 80% in the third quarter of 2026 3, and the company says most of its projects under construction are in these ecosystems 1. The strategy relies on high-quality tenants and long-term leases.
Development and redevelopment
Development covers ground-up construction of generic laboratory space, while redevelopment converts offices or industrial space into laboratories 1. In 2025 the company reduced its future construction funding needs and sold non-core assets to support its balance sheet 1.
Market context
The laboratory space market in Boston, San Francisco and San Diego has been oversupplied after a wave of conversions and speculative projects, with availability reaching about 29% in 2025, against roughly 4% in 2021 1. Tenant demand, measured by space requirements, fell by more than 60% compared with 2021 1. The company notes that policy and research funding uncertainty could lead tenants to defer leasing decisions 1.
Trends
- Oversupply of laboratory spaceheadwind
The wave of conversions and speculative projects has brought in more space than current demand, and absorption has not kept pace with supply 1. Pressure on occupancy and rents remains significant in the top markets 1.
- Weaker demand from pharmaceutical and biotech tenantsheadwind
Demand has normalised after record levels in 2021 and has returned towards the 2016-2018 range 1. The company says tensions over research funding and drug pricing policy could defer leasing commitments 1.
- Recovery in leasing and occupancymixed
Total leasing volume exceeded 1.2 million RSF in the third quarter of 2026, the highest since the fourth quarter of 2024 2. The company expects some temporarily vacant space to be occupied after works are completed 1, which could support revenue if the trend continues.
- Capital recycling and dividend adjustmentmixed
The quarterly dividend was cut by 45% in the fourth quarter of 2025 to preserve liquidity and support the 2026 capital plan 1. The company has sold non-core assets and land, and sales of partial interests can partly fund investments 2.
Competitive position
In life science real estate, competitors include other REITs, pension funds, private equity funds and institutional investors, many with greater financial resources 1. Competition can reduce the number of available investment opportunities and raise the bargaining power of sellers 1. Alexandria says it has differentiated itself through its pioneer position and long-standing industry relationships 1.
- Other REITs with laboratory assets
REITs owning laboratory space are named in the filing as rivals for tenants and acquisitions, without further detail in the sources reviewed 1.
- Pension and institutional investment funds
These are described as investors with greater financial resources that can accept more risk and offer lower rents or incentives to tenants 1.
- Private equity funds and foreign investors
The sources list them among competitors for investments, with capacity to pay higher prices for properties 1.
- Owner-occupiers and developers
Developers and owners who occupy their own space compete for land and quality properties 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- BREAKING: Democrat Alexandria Ocasio-Cortez (AOC) wins reelection to U.S. House …Telegram — Insider Paper (EN, defense leaks) · 04 Nov 2026 · EN
- Scene incredibile în Alexandria. Un poliţist plimbă bebeluşul de o lună abandonat în cărucior, în timp ce părinţii se ceartă pe stradăAdevărul · 31 Oct 2026 · RO
- Consiliul Local al Tinerilor din Alexandria a fost premiat la Gala Antena 3 CNN „Winners of the Future 2026”Antena 3 CNN · 31 Oct 2026 · RO
- Alegerile de jumătate de termen din 2026: Alexandria Ocasio-Cortez în campanie pentru candidații democrați - www.goldring.roSurge — Google News · 30 Oct 2026 · RO
- Russian Agriculture Ministry sees prospects for grain hub in AlexandriaTASS (RU, EN) · 28 Oct 2026 · EN
- Alexandria vrea să restricționeze „păcănelele”. Unde ar mai putea funcționa și ce jocuri de noroc ar rămâne permiseAdevărul · 22 Oct 2026 · RO
- O doctoriță din Alexandria care s-a urcat beată la volan a făcut accident. Se grăbea pentru că intra în gardă la UrgențeAntena 3 CNN · 15 Oct 2026 · RO
- O doctoriță de la Spitalul Alexandria, prinsă băută la volan înainte de gardă la UPU. Soțul, care nu era în mașină, a încercat să ia vina asupra luiAdevărul · 15 Oct 2026 · RO
- Descoperire rară în Egipt: un inel antic, cu imaginea Farului din Alexandria, găsit în ruinele unui palat scufundatDigi24 · 10 Oct 2026 · RO
- Un inel de bronz cu gravura Farului din Alexandria a fost descoperit într-un palat de pe o insulă scufundată din EgiptAntena 3 CNN · 10 Oct 2026 · RO
- Gala Excelenței în Educație revine la Alexandria. Aproape 100 de elevi și 16 profesori pensionari, premiațiAntena 3 CNN · 02 Oct 2026 · RO
- Alexandria Real Estate Equities Stock: Is ARE Underperforming the Real Estate Sector?Yahoo Finance — News · 17 Sept 2026 · EN
- Here’s Why Why Baron Capital Bought Alexandria (ARE)Yahoo Finance — News · 17 Sept 2026 · EN
- Autostrada București – Alexandria A6: Investiție de 11,1 miliarde lei pentru 74,22 kilometri / Ministerul Transporturilor lansează în dezbatere indicatorii tehnico-economiciEconomedia · 17 Sept 2026 · RO
- Bernie Sanders, Alexandria Ocasio-Cortez invited to Paris for Gabriel Zucman’s tax-the-rich summitPolitico EU · 10 Sept 2026 · EN
- Proiectul L.O.C.A.L. EU continuă: 17 tineri din Alexandria au învățat despre leadership și diplomație în Bulgaria și GreciaAntena 3 CNN · 09 Sept 2026 · RO
- 17 tineri din Alexandria, în vizită la Consulatul General din Salonic și pe traseul istoric Kaliakra, prin proiectul L.O.C.A.L. EUAntena 3 CNN · 07 Sept 2026 · RO
- Alexandria’s (ARE) Profit Rebound Comes With A Cash Flow CatchYahoo Finance — News · 06 Sept 2026 · EN
- 17 tineri din Alexandria explorează România, Bulgaria și Grecia prin proiectul L.O.C.A.L. EU | Study Tour 2026Antena 3 CNN · 05 Sept 2026 · RO
- Proiectul L.O.C.A.L. EU: 16 tineri din Alexandria au învățat din experiența comunităților din Germania și UngariaAntena 3 CNN · 04 Sept 2026 · RO
SEC filings
- Current report26 Oct 2026Results of operations · Financial statements and exhibits
- Quarterly report26 Oct 2026
- Current report24 Sept 2026Material agreement · Creation of a direct financial obligation
- Current report21 Aug 2026Material agreement · Creation of a direct financial obligation · Financial statements and exhibits
- Current report14 Aug 2026Other events · Financial statements and exhibits
- Current report03 Aug 2026Results of operations · Financial statements and exhibits
- Quarterly report03 Aug 2026
- Current report09 Jul 2026Material agreement · Creation of a direct financial obligation
- Current report14 May 2026Shareholder vote · Financial statements and exhibits
- Current report27 Apr 2026Results of operations · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Alexandria Real Estate Equities, Inc. · 26 Jan 2026
- [2] Form 10-Q, quarter ended 2026-09-30 · SEC / Alexandria Real Estate Equities, Inc. · 26 Oct 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Alexandria Real Estate Equities, Inc. · 26 Oct 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.